Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/E
Target Price
The average target price of FAE.MC is 5.3 and suggests 2% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell